Summary:
- Neuralink, the brain-computer interface company founded by Elon Musk, has received approval from the U.S. Food and Drug Administration (FDA) to begin human clinical trials.
- The FDA's approval is a significant milestone for Neuralink, as it paves the way for the company to test its brain implant technology in humans, which could potentially help people with neurological conditions or disabilities.
- The approval comes after Neuralink has been extensively testing its technology in animals, including successfully implanting its device in the brains of monkeys and demonstrating their ability to control a computer cursor with their thoughts.